DocDollars

Allergan, Inc.

NJ · United States · Reporting entity ID 100000000278

Total reported 2019–2025
$700.3M
#25 of 2,960 reporting companies — 0.8% of all reported industry payments
$267.5M in general payments across 1,060,720 records, plus $432.8M in research funding across 84,054 records.

How it breaks down

General payments $267,466,102
Research funding $432,823,842

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Allergan, Inc. reported $700.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #25 of 2,960 reporting companies. 62% of that was research funding and 38% general payments such as consulting, speaking, food and travel. 1,060,720 general payment records and 84,054 research records were filed.

Common questions about Allergan, Inc.

How much has Allergan, Inc. paid US doctors?

Allergan, Inc. reported $700,289,943 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $267,466,102 in general payments, $432,823,842 in research funding.

How does Allergan, Inc. rank among drug and device companies?

It ranks #25 of 2,960 reporting entities by total reported value, about 0.8% of all industry payments in the dataset.

Does a payment from Allergan, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.